Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
02/24/2005 | US20050043269 Pharmaceutically active uridine esters |
02/24/2005 | US20050043239 Administering phosphoinositide 3-kinase delta selective inhibitor effective to inhibit endogenous immune response stimulated by endogenous factor without inhibiting exogenous immune response stimulated by exogenous factor; treatment of Inflammatory responses, immune responses |
02/24/2005 | US20050042738 Carbohydrate-associated proteins |
02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
02/24/2005 | US20050042671 Modulation of angiogenesis |
02/24/2005 | US20050042667 Expression vector comprising nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of immune, hematopoietic, inflammatory and tumor diseases |
02/24/2005 | US20050042317 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
02/24/2005 | US20050042312 Solubility and Absorption Promoter |
02/24/2005 | US20050042308 Soft capsules containing mint oil with analgesics, antiinflammatory agents ; complex |
02/24/2005 | US20050042266 Cyanoacrylate compositions containing anti-microbial agent |
02/24/2005 | US20050042243 Oat extracts: refining, compositions and methods of use |
02/24/2005 | US20050042237 Method for administering a spill resistant pharmaceutical system |
02/24/2005 | US20050042202 Gentamicin, amikacin, tobramycin, netilmicin, cephalosporin, ceftazidine, maxalactam, carbopenem, imipenem, aztreonam, ampicillin, penicillin, ureidopenicillin, augmentin, amphotericin, famvir and/or acyclovir; and Vpr protein, fragment or nucleic acid encoding; systemic inflammatory response syndrome |
02/24/2005 | US20050042201 Synergistic mixture of glycoprotein and angiogenesis inhibitor comprising angiostatin, thrombostatin, endostatin, interferon, interferon-inducible factor 10, platelet factor, and/or cyclooxygenase inhibitor; antitumor and anticarcinogenic agents |
02/24/2005 | CA2530604A1 Combinatorial synthesis on support |
02/24/2005 | CA2518774A1 Heterocyclic n-aryl carboxamides as cytokine inhibitors |
02/23/2005 | EP1508601A1 Cyanoacrylate compositions containing anti-microbial agent |
02/23/2005 | EP1508570A1 Novel physiolgically active substances |
02/23/2005 | EP1508327A1 Use of chromen-4-one derivatives for the care of skin and hair |
02/23/2005 | EP1507875A2 Assay for identifying inhibitors of fc gamma riii signaling |
02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
02/23/2005 | EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
02/23/2005 | EP1507779A1 Inhibitors of jak and cdk2 protein kinases |
02/23/2005 | EP1507775A1 Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
02/23/2005 | EP1507772A1 Methods of using thiazolidinedithione derivatives |
02/23/2005 | EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
02/23/2005 | EP1507759A1 Cyanoguanidine produgs |
02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
02/23/2005 | EP1507754A1 Alkoxy aryl beta-2 adrenergic receptor agonists |
02/23/2005 | EP1507554A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
02/23/2005 | EP1507545A1 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere |
02/23/2005 | EP1507539A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
02/23/2005 | EP1507536A2 Compositions and their uses for alleviating pain |
02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
02/23/2005 | EP1507533A2 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
02/23/2005 | EP1313489B1 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
02/23/2005 | EP1133482B1 Il-5 inhibiting 6-azauracil derivatives |
02/23/2005 | EP1058544B1 Inhibition of tnf activity with compositions comprising heparin and soluble tnf recpetors |
02/23/2005 | CN2680261Y Anti-inflammatory plaster |
02/23/2005 | CN1585778A Modified anti-TNF alpha antibody |
02/23/2005 | CN1585777A 肝脏x受体激动剂 Liver x receptor agonist |
02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
02/23/2005 | CN1585770A Reverse-turn mimetics and method relating thereto |
02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
02/23/2005 | CN1585750A Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
02/23/2005 | CN1585749A Cannabinoid receptor ligands |
02/23/2005 | CN1585748A NK1 antagonists |
02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
02/23/2005 | CN1585648A Enamel matrix protein compositions for modulating immune response |
02/23/2005 | CN1585647A Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases |
02/23/2005 | CN1585641A Hydrazono-malonitriles |
02/23/2005 | CN1585640A N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
02/23/2005 | CN1585638A Linked biaryl compounds |
02/23/2005 | CN1585635A 2-(4-isobutylphenyl) propionic acid medicinal composition |
02/23/2005 | CN1585630A Method for the formation of ibuprofen crystals |
02/23/2005 | CN1585627A Microfabricated nanopore device for sustained release of therapeutic agent |
02/23/2005 | CN1583791A Extraction and purification of sheep skin growth factor as medicine for inflammatory enteropathy |
02/23/2005 | CN1583745A Amino biological pterin derivative and pharmaceutical use thereof |
02/23/2005 | CN1583158A Medicinal composition for wind-cold pathogen by exopathogen and its preparation |
02/23/2005 | CN1583151A Medicinal spirit for rheumatism |
02/23/2005 | CN1583147A Preparation of oriental waterplantain pieces |
02/23/2005 | CN1583142A Pills for promoting blood circulation and removing obstruction in channels |
02/23/2005 | CN1583126A Effervescent tablets for promoting blood circulation, removing blood stasis and stopping pain |
02/23/2005 | CN1583123A Medicinal spirit for rheumatism |
02/23/2005 | CN1583119A Medicine for cold and pain of abdomen before and during menstruation and its preparation |
02/23/2005 | CN1583086A Chinese medicine for relieving exterior syndrome, regulating stomach and eliminatnig dampness and its production |
02/23/2005 | CN1583085A Chinese patent medicine for injury of muscle and joint and its preparation |
02/23/2005 | CN1583080A Prescription of |
02/23/2005 | CN1583076A Prescription of |
02/23/2005 | CN1583063A Extraction of effective components from frankinscene and its preparation and use |
02/23/2005 | CN1583060A Chinese patent medicine for enterogastric heat retention waist and knee aching pain and joint tingling and its preparation |
02/23/2005 | CN1583059A One-course and three paste pain relieving paste |
02/23/2005 | CN1583058A Medicinal spirit for rheumatic arthritis |
02/23/2005 | CN1583055A Chinese medicinal capsules for disinfecting and relieving toxicity and their preparation |
02/23/2005 | CN1583051A Dispersal tablets of thesium Chinese and their preparation |
02/23/2005 | CN1583043A Duyiwei extract and its preparation and use |
02/23/2005 | CN1583026A Paste for pain caused by shoulder periarthritis |
02/23/2005 | CN1583017A Medicine for rheumatism and its preparation |
02/23/2005 | CN1583010A Extracts of Chinese medicines for rheumatism and its preparation and preparing method |
02/23/2005 | CN1583000A Chinese medicine for removing obstruction in channels and relieving pains and its preparation |
02/23/2005 | CN1582978A Medicine for clearing away damp-heat and reducing leukorrhea |
02/23/2005 | CN1582973A Garlic frozen dry capsules and their preparation |
02/23/2005 | CN1582961A Improved Chinese medicinal paste for arthralgia and its preparation |
02/23/2005 | CN1582945A Powder injections of composite monoammonium glycyrrhizinate and their preparation |
02/23/2005 | CN1582931A Oral sustained releasing micro-tablets of tuduranine and their preparation |
02/23/2005 | CN1582924A Skin penetrating paste of indomethacin albuterol |
02/23/2005 | CN1582908A Tramadol hydrochloride drops and their preparation |
02/23/2005 | CN1190491C PRV-gene and use thereof |
02/23/2005 | CN1190437C Pteridine compounds for treatment of psoriasis |
02/23/2005 | CN1190424C Quinoline-containing Alpha-ketoamide cysteine and serine protease inhibitors |
02/23/2005 | CN1190416C Substituted phenyl alkyl nitrogen monoxide synthase inhibitor and its prepn. and use |
02/23/2005 | CN1190227C External-use Chinese medicine preparation for wind-dispelling and dampness-removing and preparing method thereof |